SLC16A1 and glioma: The study revealed the correlation between the level of MCT1 or CD147 in exosomes, which represented the gain or loss of function of MCT1 or CD147 in glioma cells, and the malignant phenotypes of glioma cells, such as migration and proliferation (Thakur et al., 2020c).